GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemostemix Inc (OTCPK:HMTXF) » Definitions » E10

HMTXF (Hemostemix) E10 : $-0.53 (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Hemostemix E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hemostemix's adjusted earnings per share data for the three months ended in Sep. 2024 was $-0.011. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.53 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-14), Hemostemix's current stock price is $0.0827. Hemostemix's E10 for the quarter that ended in Sep. 2024 was $-0.53. Hemostemix's Shiller PE Ratio of today is .


Hemostemix E10 Historical Data

The historical data trend for Hemostemix's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemostemix E10 Chart

Hemostemix Annual Data
Trend May14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -0.79 -0.58

Hemostemix Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.63 -0.58 -0.58 -0.34 -0.53

Competitive Comparison of Hemostemix's E10

For the Biotechnology subindustry, Hemostemix's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hemostemix's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemostemix's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hemostemix's Shiller PE Ratio falls into.



Hemostemix E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hemostemix's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.011/127.2847*127.2847
=-0.011

Current CPI (Sep. 2024) = 127.2847.

Hemostemix Quarterly Data

per share eps CPI Adj_EPS
201408 0.000 99.315 0.000
201412 -0.486 98.367 -0.629
201503 -0.148 99.789 -0.189
201506 -0.302 100.500 -0.382
201509 -0.281 100.421 -0.356
201512 -0.272 99.947 -0.346
201603 -0.141 101.054 -0.178
201606 -0.145 102.002 -0.181
201609 -0.305 101.765 -0.381
201612 -0.300 101.449 -0.376
201703 -0.149 102.634 -0.185
201706 -0.150 103.029 -0.185
201709 -0.326 103.345 -0.402
201712 -0.049 103.345 -0.060
201803 -0.056 105.004 -0.068
201806 -0.152 105.557 -0.183
201809 -0.153 105.636 -0.184
201812 -0.149 105.399 -0.180
201903 -0.150 106.979 -0.178
201906 -0.060 107.690 -0.071
201909 -0.076 107.611 -0.090
201912 -0.033 107.769 -0.039
202003 -0.005 107.927 -0.006
202006 -0.041 108.401 -0.048
202009 -0.033 108.164 -0.039
202012 -0.089 108.559 -0.104
202103 -0.010 110.298 -0.012
202106 -0.019 111.720 -0.022
202109 -0.014 112.905 -0.016
202112 -0.043 113.774 -0.048
202203 -0.021 117.646 -0.023
202206 -0.016 120.806 -0.017
202209 -0.008 120.648 -0.008
202212 -0.010 120.964 -0.011
202303 -0.012 122.702 -0.012
202306 -0.003 124.203 -0.003
202309 -0.018 125.230 -0.018
202312 -0.020 125.072 -0.020
202406 -0.004 127.522 -0.004
202409 -0.011 127.285 -0.011

Add all the adjusted EPS together and divide 10 will get our e10.


Hemostemix  (OTCPK:HMTXF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Hemostemix E10 Related Terms

Thank you for viewing the detailed overview of Hemostemix's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Hemostemix Business Description

Traded in Other Exchanges
Address
707 - 7th Avenue SouthWest, Suite 1150, Calgary, AB, CAN, T2P 3H6
Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company's clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.